Skip to content

Clinical trials

Urinary Bladder Neoplasms trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Country / region: Portugal Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20151
20162
20182
20191
20203
20213
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting7
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Astellas Pharma Global Development, Inc.1
Bristol-Myers Squibb1
Janssen-Cilag Farmaceutica Ltda.1
Medicenna Therapeutics, Inc.1
Nektar Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms18
Carcinoma, Transitional Cell4
Colorectal Neoplasms2
Endometrial Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Uterine Cervical Neoplasms2
Basal Cell Carcinoma1
Biliary Tract Neoplasms1
Carcinoma, Merkel Cell1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.